by David Prentice, PhD, William L. Saunders, JD, Jan Ledochowski, and Lukas Lucenic
FDA Approves First Clinical Trial with Human Embryonic Stem Cells: The Audacity of Hope
Decision shows, once again, that embryonic stem cells still lag far behind
adult stem cells in treating patients - DoNoHarm
False Promises: Common Cloning Claims Refuted
Pro-cloning forces have been working hard to convince state governments to pass constitutional amendments enshrining a "right" to clone and to destroy embryos for research. Such amendments promise medical cures, limitless profits, and ethical benchmarks. But all of these promises are false. In this pamphlet we show how such claims fall apart, and how you can effectively oppose cloning amendments in your state.
USCCB Issues Statement on Embryonic Stem Cell Research
June 13, 2008
Stem cell research has captured the imagination of many in our society. Stem cells are relatively unspecialized cells that, when they divide, can replicate themselves and also produce a variety of more specialized cells.
Patients First: Doctor and Patient on Current Adult Stem Cell Benefits
March 13, 2008
Capitol Hill briefing by patients and the doctor who treated them on the therapeutic benefits already being realized with adult stem cell treatments. Patients' Stories
Adult versus Embryonic Stem Cells:
Treatments
The journal Science has published a second Letter from DoNoHarm
An Encore Toast to Adult and Cord Blood
Stem Cells
In
the campaign to promote taxpayer funding of stem cell
research that requires destroying human embryos, political hype
often substitutes for the scientific facts. This series
of one-page "lessons" responds to mere politics with
science.
Embryonic stem cells pose an unusual risk for genetic
changes and tumor formation, with the risk increasing
the longer the cells are grown, thus making their
therapeutic use even more speculative and problematic - Do No Harm
Open Letter from 57 Scientists andPhysicians on Sen. John Kerry's Claims About
Embryonic Stem Cells